{
    "doi": "https://doi.org/10.1182/blood-2021-151317",
    "article_title": "Discovery of TSC-101: A First-in-Class Natural HA-2-Specific TCR to Treat Leukemia Following Hematopoietic Stem Cell Transplant Therapy ",
    "article_date": "November 5, 2021",
    "session_type": "703.Cellular Immunotherapies: Basic and Translational",
    "abstract_text": "Background Approximately 50% of AML patients relapse following allogeneic hematopoietic stem cell transplant therapy, leaving them with very few treatment options (Rautenberg et al . (2019) Int. J. Mol. Sci. 20:228). Rare patients who naturally develop a minor antigen-specific graft-versus-leukemia T cell response show substantially lower relapse rates (Marijt et al. (2003) Proc. Natl. Acad. Sci. U.S.A. 100:2742-2747; Spierings et al. (2013) Biol. Blood Marrow Transplant. 19:1244-1253). HA-2 (YIGEVLVSV, genotype RS_61739531 C/C or T/C) is an HLA-A*02:01- and haematopoietically-restricted minor histocompatibility antigen derived from the class I myosin protein, MYO1G (Pierce et al . (2001) J. Immunol. 167:3223-3230). Patients receiving donor lymphocyte infusion from HA-2-mismatched donors who develop HA-2-specific T cells show a graft vs leukemia response and often experience long-term remission (Marijt et al. (2003) Proc. Natl. Acad. Sci. U.S.A. 100:2742-2747), making HA-2 an ideal candidate for TCR-engineered T cell immunotherapy of liquid tumors. Methods Using TScan's proprietary ReceptorScan platform, we discovered 1,302 HA-2-specific TCRs by screening 237 million na\u00efve CD8 + T cells from 5 healthy HA-2-negative donors. We evaluated these TCRs using our proprietary DexScan platform to select the 15 TCRs with the highest surface expression and greatest affinity for the HA-2 peptide when transferred into primary human T cells. We further tested each TCR individually in our clinical vector backbone for surface expression, selective cytotoxicity, cytokine production, and proliferation using a panel of cell lines that express varying levels of HLA-A*02:01 and MYO1G. Finally, the top 5 TCRs were evaluated for alloreactivity using an array-based screen assessing 108 MHC-I molecules individually, and for off-target cross-reactivity using our proprietary genome-wide TargetScan platform. A lead TCR with limited alloreactivity and a narrow off-target profile was selected as our lead TSC-101 TCR. The avidity of TSC-101 for its putative off-targets was further measured in peptide-pulsed experiments to better appreciate the toxicity risks associated with our lead clinical candidate. Results and Conclusion Of the 1,302 HA-2-specific TCRs identified by our ReceptorScan platform, we identified TSC-101 as the most active TCR. TSC-101 displayed no alloreactivity to 107/108 HLAs tested and limited off-target risks in a genome-wide screens. Potential off-target peptides identified for TSC-101 displayed extremely weak avidities, predicting an absence of toxicity risks for our clinical candidate. Based on these results, TSC-101 has been advanced to IND-enabling activities to prepare for first-in-human testing in 2022. To our knowledge, this is the first clinical grade HA-2-specifc TCR being developed for immunotherapy for liquid tumors. Disclosures Macbeath:  TScan Therapeutics: Current Employment, Current equity holder in publicly-traded company.",
    "author_names": [
        "Ribhu Nayar",
        "Mollie M Jurewicz",
        "Sonal Jangalwe",
        "Hannah Bader",
        "Kimberly M Cirelli",
        "Andrew Basinski",
        "Daniel Pollacksmith",
        "Alexandra Luther",
        "Cisem Karaca",
        "Anna Labrozzi",
        "Krista Daniel",
        "Lisa Nip",
        "Danielle Ramsdell",
        "Amy Virbasius",
        "Candace Perullo",
        "Kenneth L Jahan",
        "Sida Liao",
        "Livio Dukaj",
        "Alexandra Cristofaro",
        "Shrikanta Chattopadhyay",
        "Kenneth Olivier",
        "Antoine J Boudot",
        "Qikai Xu",
        "Yifan Wang",
        "Cagan Gurer",
        "Gavin Macbeath"
    ],
    "author_dict_list": [
        {
            "author_name": "Ribhu Nayar",
            "author_affiliations": [
                "TScan Therapeutics, Waltham, MA"
            ],
            "author_rank": 1,
            "first_author": 1,
            "last_author": 0
        },
        {
            "author_name": "Mollie M Jurewicz",
            "author_affiliations": [
                "TScan Therapeutics, Waltham, MA"
            ],
            "author_rank": 2,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Sonal Jangalwe",
            "author_affiliations": [
                "TScan Therapeutics, Waltham, MA"
            ],
            "author_rank": 3,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Hannah Bader",
            "author_affiliations": [
                "TScan Therapeutics, Waltham, MA"
            ],
            "author_rank": 4,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Kimberly M Cirelli",
            "author_affiliations": [
                "TScan Therapeutics, Waltham, MA"
            ],
            "author_rank": 5,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Andrew Basinski",
            "author_affiliations": [
                "TScan Therapeutics, Waltham, MA"
            ],
            "author_rank": 6,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Daniel Pollacksmith",
            "author_affiliations": [
                "TScan Therapeutics, Waltham, MA"
            ],
            "author_rank": 7,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Alexandra Luther",
            "author_affiliations": [
                "TScan Therapeutics, Waltham, MA"
            ],
            "author_rank": 8,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Cisem Karaca",
            "author_affiliations": [
                "TScan Therapeutics, Waltham, MA"
            ],
            "author_rank": 9,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Anna Labrozzi",
            "author_affiliations": [
                "TScan Therapeutics, Waltham, MA"
            ],
            "author_rank": 10,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Krista Daniel",
            "author_affiliations": [
                "TScan Therapeutics, Waltham, MA"
            ],
            "author_rank": 11,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Lisa Nip",
            "author_affiliations": [
                "TScan Therapeutics, Waltham, MA"
            ],
            "author_rank": 12,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Danielle Ramsdell",
            "author_affiliations": [
                "TScan Therapeutics, Waltham, MA"
            ],
            "author_rank": 13,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Amy Virbasius",
            "author_affiliations": [
                "TScan Therapeutics, Waltham, MA"
            ],
            "author_rank": 14,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Candace Perullo",
            "author_affiliations": [
                "TScan Therapeutics, Waltham, MA"
            ],
            "author_rank": 15,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Kenneth L Jahan",
            "author_affiliations": [
                "TScan Therapeutics, Waltham, MA"
            ],
            "author_rank": 16,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Sida Liao",
            "author_affiliations": [
                "TScan Therapeutics, Waltham, MA"
            ],
            "author_rank": 17,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Livio Dukaj",
            "author_affiliations": [
                "TScan Therapeutics, Waltham, MA"
            ],
            "author_rank": 18,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Alexandra Cristofaro",
            "author_affiliations": [
                "TScan Therapeutics, Waltham, MA"
            ],
            "author_rank": 19,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Shrikanta Chattopadhyay",
            "author_affiliations": [
                "TScan Therapeutics, Waltham, MA"
            ],
            "author_rank": 20,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Kenneth Olivier",
            "author_affiliations": [
                "TScan Therapeutics, Waltham, MA"
            ],
            "author_rank": 21,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Antoine J Boudot",
            "author_affiliations": [
                "TScan Therapeutics, Waltham, MA"
            ],
            "author_rank": 22,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Qikai Xu",
            "author_affiliations": [
                "TScan Therapeutics, Waltham, MA"
            ],
            "author_rank": 23,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Yifan Wang",
            "author_affiliations": [
                "TScan Therapeutics, Waltham, MA"
            ],
            "author_rank": 24,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Cagan Gurer",
            "author_affiliations": [
                "TScan Therapeutics, Waltham, MA"
            ],
            "author_rank": 25,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Gavin Macbeath",
            "author_affiliations": [
                "TScan Therapeutics, Waltham, MA"
            ],
            "author_rank": 26,
            "first_author": 0,
            "last_author": 1
        }
    ],
    "datetime_abstract_obtained": "2022-06-22T02:39:28",
    "is_scraped": "1"
}